[Hypercholesterolemia, practical guidelines].
Dallongeville
J
J
INSERM U508, Institut Pasteur, Lille, France.
Ferrières
J
J
Schuster
H
H
Farnier
M
M
Lepen
C
C
D001161:Arteriosclerosis / Q000209:etiology / Q000517:prevention & control; D002097:C-Reactive Protein / Q000032:analysis; D005464:Fluorobenzenes / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006937:Hypercholesterolemia / Q000150:complications / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D011743:Pyrimidines / Q000627:therapeutic use*; D012307:Risk Factors; D000068718:Rosuvastatin Calcium; D013449:Sulfonamides / Q000627:therapeutic use*
D005464:Fluorobenzenes; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011743:Pyrimidines; D013449:Sulfonamides; D000068718:Rosuvastatin Calcium; D002097:C-Reactive Protein